Proxima AB has acquired Björkhagen Vårdcentral AB
Juni 2010 — Proxima AB, a Swedish private equity-owned medical care provider, has acquired Björkhagen Vårdcentral AB from the management team for an undisclosed consideration.
Proxima is a private healthcare group owned by CapMan, a private equity company listed on the Finnish stock exchange. Proxima is active in primary healthcare, diagnostics and specialist healthcare. Specialist healthcare is conducted in Nacka hospital, Motala hospital and the surgical clinic in Östermalm, Stockholm. "The acquisition of Björkhagens Vårdcentral is yet another step in our goal to offer our patients the best and most extensive local hospital care," said Thomas Andersson, CEO of Proxima primary care.
Björkhagen is located in the south of Stockholm, an area with large growth potential. The proximity to Nacka hospital, where Proxima conducts extensive specialist healthcare, will benefit patients. The healthcare center in Björkhagen was founded in 2001, when it was taken over by the county council.
Vår roll i transaktionen
Oaklins' team in Sweden advised the buyer in this transaction. This transaction is the first in a series of acquisitions following an initial strategic analysis resulting in a growth-oriented business plan that includes strategic acquisitions for Proxima AB.
Prata med transaktionsteamet
Relaterade transaktioner
UKAT Group has acquired Bayberry Limited
UK Addiction Treatment (UKAT) Group, a leading UK provider of residential addiction, mental health and behavioral health treatment backed by Sullivan Street Partners, has acquired Bayberry Limited, a specialist mental health and wellbeing treatment provider. Joining UKAT enables Bayberry to preserve continuity of care for patients and referral partners, retain the strength of its clinical team and benefit from UKAT’s operational infrastructure, referral network and marketing channels. This partnership supports Bayberry’s next stage of development while preserving the qualities that differentiate its service offering.
Lär dig merMedicija has acquired Saulės Šeimos Medicinos Centras
Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.
Lär dig merQuimpharma has completed the divestiture of a product portfolio to Megalabs
Quimpharma has completed the divestiture of a product portfolio to Megalabs México.
Lär dig mer